[Positron emission tomography (PET) in clinical oncology. Part II]

Rev Esp Med Nucl. 2002 Apr;21(2):131-47; quiz 149-51. doi: 10.1016/s0212-6982(02)72051-x.

[Article in Spanish]

Authors

A Cabrera Villegas¹, C Gámez Cenzano, J C Martín Urreta

Affiliation

¹ Servicio de Medicina Nuclear, Unidad PET, Clinica Vicente San Sebastián, Bilbao, Spain.

PMID: 11879626
DOI: 10.1016/s0212-6982(02)72051-x

No abstract available

Publication types

Review

MeSH terms

Adult
Aged
Colorectal Neoplasms / diagnostic imaging
False Negative Reactions
False Positive Reactions
Female
Fluorine Radioisotopes
Fluorodeoxyglucose F18
Humans
Lung Neoplasms / diagnostic imaging
Lymph Nodes / diagnostic imaging
Lymphoma / diagnostic imaging
Male
Melanoma / diagnostic imaging
Middle Aged
Neoplasm Metastasis
Neoplasm Recurrence, Local / diagnostic imaging
Neoplasms / diagnostic imaging*
Predictive Value of Tests
Radiopharmaceuticals
Sensitivity and Specificity
Tomography, Emission-Computed*
Tomography, X-Ray Computed

Substances

Fluorine Radioisotopes
Radiopharmaceuticals
Fluorodeoxyglucose F18